Correlation Between ZyVersa Therapeutics and Palisade Bio
Can any of the company-specific risk be diversified away by investing in both ZyVersa Therapeutics and Palisade Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ZyVersa Therapeutics and Palisade Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ZyVersa Therapeutics and Palisade Bio, you can compare the effects of market volatilities on ZyVersa Therapeutics and Palisade Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ZyVersa Therapeutics with a short position of Palisade Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of ZyVersa Therapeutics and Palisade Bio.
Diversification Opportunities for ZyVersa Therapeutics and Palisade Bio
0.81 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between ZyVersa and Palisade is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding ZyVersa Therapeutics and Palisade Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Palisade Bio and ZyVersa Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ZyVersa Therapeutics are associated (or correlated) with Palisade Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Palisade Bio has no effect on the direction of ZyVersa Therapeutics i.e., ZyVersa Therapeutics and Palisade Bio go up and down completely randomly.
Pair Corralation between ZyVersa Therapeutics and Palisade Bio
Given the investment horizon of 90 days ZyVersa Therapeutics is expected to under-perform the Palisade Bio. In addition to that, ZyVersa Therapeutics is 1.28 times more volatile than Palisade Bio. It trades about -0.11 of its total potential returns per unit of risk. Palisade Bio is currently generating about -0.05 per unit of volatility. If you would invest 603.00 in Palisade Bio on August 27, 2024 and sell it today you would lose (359.00) from holding Palisade Bio or give up 59.54% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
ZyVersa Therapeutics vs. Palisade Bio
Performance |
| Timeline |
| ZyVersa Therapeutics |
| Palisade Bio |
ZyVersa Therapeutics and Palisade Bio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ZyVersa Therapeutics and Palisade Bio
The main advantage of trading using opposite ZyVersa Therapeutics and Palisade Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ZyVersa Therapeutics position performs unexpectedly, Palisade Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Palisade Bio will offset losses from the drop in Palisade Bio's long position.| ZyVersa Therapeutics vs. Cns Pharmaceuticals | ZyVersa Therapeutics vs. Immix Biopharma | ZyVersa Therapeutics vs. Hepion Pharmaceuticals | ZyVersa Therapeutics vs. Zura Bio Limited |
| Palisade Bio vs. Zura Bio Limited | Palisade Bio vs. Altamira Therapeutics | Palisade Bio vs. Immix Biopharma | Palisade Bio vs. Enveric Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |